These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8215782)

  • 1. [Mechanisms of vascular hypertrophy in hypertension].
    Tedgui A
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():67-72. PubMed ID: 8215782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle in hypertension.
    Winquist RJ; Webb RC; Bohr DF
    Fed Proc; 1982 Jun; 41(8):2387-93. PubMed ID: 6282652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance control in hypertension.
    Korner PI; Bobik A; Angus JA; Adams MA; Friberg P
    J Hypertens Suppl; 1989 Sep; 7(4):S125-34; discussion S135. PubMed ID: 2681590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Franz Volhard lecture. Increased systemic vascular resistance and primary hypertension: the expanding complexity.
    Shepherd JT
    J Hypertens Suppl; 1990 Dec; 8(7):S15-27. PubMed ID: 2095384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II, vascular structure and blood pressure.
    Lever AF; Lyall F; Morton JJ; Folkow B
    Kidney Int Suppl; 1992 Jun; 37():S51-5. PubMed ID: 1385840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms regulating vascular function and structure--implications in the pathogenesis of hypertension.
    Touyz RM
    Can J Cardiol; 2000 Sep; 16(9):1137-46. PubMed ID: 11021957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small artery remodeling in diabetes mellitus.
    Rizzoni D; Rosei EA
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):587-92. PubMed ID: 19481431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New aspects of the pathophysiology and pathogenesis of arterial hypertension--a review of the literature].
    Franz C; Linss G; Franz N
    Z Gesamte Inn Med; 1990 Dec; 45(24):723-8. PubMed ID: 2151671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular growth in hypertension.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S7-11. PubMed ID: 1380621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms of diabetic vascular hypertrophy.
    Vranes D; Cooper ME; Dilley RJ
    Microvasc Res; 1999 Jan; 57(1):8-18. PubMed ID: 9882558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.
    Dikalova A; Clempus R; Lassègue B; Cheng G; McCoy J; Dikalov S; San Martin A; Lyle A; Weber DS; Weiss D; Taylor WR; Schmidt HH; Owens GK; Lambeth JD; Griendling KK
    Circulation; 2005 Oct; 112(17):2668-76. PubMed ID: 16230485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophy of the arterial wall and arterial rigidity].
    Laurent S; Boutouyrie P
    Pathol Biol (Paris); 1999 Jun; 47(6):648-55. PubMed ID: 10472076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral vascular physiology in hypertensive disease.
    Williams JL; Furlan AJ
    Neurosurg Clin N Am; 1992 Jul; 3(3):509-20. PubMed ID: 1633475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.